ClearPoint Neuro, Inc.
CLPT
Rank in Stocks
#14903
ClearPoint Neuro, Inc. is a medical technology firm primarily operating within... ClearPoint Neuro, Inc. is a medical technology firm primarily operating within the United States. The company specializes in developing and commercializing sophisticated systems that facilitate minimally invasive brain surgeries, guided by real-time magnetic resonance imaging (MRI) during the procedure. Among its core offerings is the ClearPoint system, designed for the precise placement of deep brain stimulation electrodes, biopsy needles, and for the controlled infusion of medications and laser catheters directly into the brain. It also provides the ClearPoint Neuro Navigation System, which is specifically engineered for MRI suite environments. ClearPoint Neuro maintains strategic partnerships and licensing agreements with prominent institutions and companies, including Boston Scientific Corporation, The Johns Hopkins University, Clinical Laserthermia Systems Americas Inc, Koninklijke Philips N.V., Blackrock Neurotech, and the University of California, San Francisco. Initially established in 1998 and headquartered in Solana Beach, California, the company operated as MRI Interventions, Inc. before rebranding to ClearPoint Neuro, Inc. in February 2020.
Share Price
$9.17
Last synced: 2026-11-09
Market Cap
$293.94M
Change (1 day)
6.63%
Change (1 year)
-47.30%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade ClearPoint Neuro, Inc. (CLPT)
Category
Healthcare
Operating Margin for ClearPoint Neuro, Inc. (CLPT)
Operating Margin as of November 2026 TTM: -70.56%
According to ClearPoint Neuro, Inc.'s latest financial reports, its current operating margin (TTM) is -70.56%. At the end of 2025 the company had an operating margin of -65.36%.
Operating Margin history for ClearPoint Neuro, Inc. from 2010 to 2026
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2026 (TTM) | -70.56% | 7.96% |
| 2025 | -65.36% | 3.89% |
| 2024 | -62.91% | -32.86% |
| 2023 | -93.70% | 17.91% |
| 2022 | -79.47% | -3.14% |
| 2021 | -82.05% | 69.25% |
| 2020 | -48.48% | 18.36% |
| 2019 | -40.96% | -42.61% |
| 2018 | -71.37% | -16.88% |
| 2017 | -85.86% | -34.08% |
| 2016 | -130.25% | -33.32% |
| 2015 | -195.34% | 32.34% |
| 2014 | -147.61% | -22.38% |
| 2013 | -190.17% | 207.37% |
| 2012 | -61.87% | -60.11% |
| 2011 | -155.09% | -56.49% |
| 2010 | -356.45% | 0.00% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin Difference | Country |
|---|---|---|---|
| 15.24% | -100.22% |
US
|
|
| 18.08% | -100.26% |
IE
|
|
| 21.25% | -100.30% |
US
|
|
| 21.05% | -100.30% |
US
|
|
| 28.09% | -100.40% |
US
|
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.
Questions about ClearPoint Neuro, Inc.'s operating margin
What is ClearPoint Neuro, Inc.'s operating margin?
ClearPoint Neuro, Inc.'s operating margin is -70.56%, as of Nov 2026.
What was ClearPoint Neuro, Inc.'s operating margin in 2025?
In 2025, ClearPoint Neuro, Inc.'s operating margin was -65.36%, compared with -62.91% in 2024.
How has ClearPoint Neuro, Inc.'s operating margin changed since 2020?
From 2020 to 2025, ClearPoint Neuro, Inc.'s operating margin was highest in 2020 (-48.48%) and lowest in 2023 (-93.70%).
How does ClearPoint Neuro, Inc.'s operating margin compare with similar companies?
ClearPoint Neuro, Inc.'s operating margin (-70.56%) is lower than that of all 5 similar companies listed above. The highest among them is Edwards Lifesciences Corporation, with 28.09%.